{"id":"spironolacton","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Gynecomastia","drugRate":"","severity":"common","organSystem":""},{"effect":"Hyperkalemia","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"","severity":"common","organSystem":""},{"effect":"Leg cramps","drugRate":"","severity":"common","organSystem":""},{"effect":"Drowsiness","drugRate":"","severity":"common","organSystem":""},{"effect":"Lethargy","drugRate":"","severity":"common","organSystem":""},{"effect":"Irregular menses or amenorrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Decreased libido","drugRate":"","severity":"common","organSystem":""},{"effect":"Gastritis","drugRate":"","severity":"common","organSystem":""},{"effect":"Cramping","drugRate":"","severity":"common","organSystem":""},{"effect":"Pruritus","drugRate":"","severity":"common","organSystem":""},{"effect":"Alopecia","drugRate":"","severity":"common","organSystem":""},{"effect":"Mental confusion","drugRate":"","severity":"common","organSystem":""},{"effect":"Ataxia","drugRate":"","severity":"common","organSystem":""},{"effect":"Hyponatremia","drugRate":"","severity":"common","organSystem":""},{"effect":"Electrolyte disturbances","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Acute nephropathy","Acute pancreatitis","Anuria","Azotemia","Dehydration","Diabetes mellitus","Gout","Hepatic coma","Hypercalcemia","Hypercholesterolemia","Hyperkalemia","Hyperparathyroidism","Hyperuricemia","Hypochloremic alkalosis","Hypokalemia","Hypomagnesemia","Hyponatremia","Hypovolemia","Kidney disease","Metabolic acidosis, normal anion gap, acidifying salts","Neonatal hyperbilirubinemia","Secondary angle-closure glaucoma","Sympathectomy","Systemic lupus erythematosus"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Stevens-Johnson Syndrome (SJS)","drugRate":"","severity":"serious"},{"effect":"Toxic epidermal necrolysis (TEN)","drugRate":"","severity":"serious"},{"effect":"Anaphylactic reactions","drugRate":"","severity":"serious"},{"effect":"Renal failure","drugRate":"","severity":"serious"},{"effect":"Hepatocellular toxicity","drugRate":"","severity":"serious"},{"effect":"Agranulocytosis","drugRate":"","severity":"serious"},{"effect":"Thrombocytopenia","drugRate":"","severity":"serious"},{"effect":"Gastric bleeding","drugRate":"","severity":"serious"},{"effect":"Vasculitis","drugRate":"","severity":"serious"},{"effect":"Drug rash with eosinophilia and systemic symptoms (DRESS)","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL1393","moleculeType":"Small molecule","molecularWeight":"416.58"},"aliases":["Spironolacton Sandoz"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Spironolacton","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:02:27.818094+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:02:33.697900+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Spironolacton","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:02:34.009300+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Mineralocorticoid receptor antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:02:35.066467+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1393/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:02:34.726430+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"2efb4720-625f-6616-b6f0-8b13a17c9d7e","title":"SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK]"},"ecosystem":[],"mechanism":{"target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2"},"_scrapedAt":"2026-03-28T02:55:40.248Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:02:37.040528+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Aldosteronism","diseaseId":"aldosteronism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Ascites","diseaseId":"ascites","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic heart failure","diseaseId":"chronic-heart-failure","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Diagnostic Test for Primary Aldosteronism","diseaseId":"diagnostic-test-for-primary-aldosteronism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Edema","diseaseId":"edema","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Edema due to Hepatic Cirrhosis","diseaseId":"edema-due-to-hepatic-cirrhosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Edema due to Nephrotic Syndrome","diseaseId":"edema-due-to-nephrotic-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hypertensive disorder","diseaseId":"hypertensive-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hypokalemia Prevention","diseaseId":"hypokalemia-prevention","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Peripheral Edema due to Chronic Heart Failure","diseaseId":"peripheral-edema-due-to-chronic-heart-failure","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pulmonary Edema due to Chronic Heart Failure","diseaseId":"pulmonary-edema-due-to-chronic-heart-failure","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04789239","phase":"PHASE2","title":"OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Michael Fu","startDate":"2021-09-01","conditions":"Heart Failure, Hyperkalemia","enrollment":110},{"nctId":"NCT07020104","phase":"NA","title":"The Role of Skin Sodium Accumulation in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-01-07","conditions":"Chronic Kidney Diseases","enrollment":60},{"nctId":"NCT02556450","phase":"PHASE2","title":"Bioprofiling Response to Mineralocorticoid Receptor Antagonists for the Prevention of Heart Failure","status":"COMPLETED","sponsor":"ACS Biomarker","startDate":"2016-01","conditions":"Heart Failure","enrollment":528},{"nctId":"NCT00843388","phase":"PHASE4","title":"A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria","status":"UNKNOWN","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2009-03","conditions":"Diabetes Mellitus, Nephropathy, Blood Pressure","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL1393"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":27,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Spironolacton","genericName":"Spironolacton","companyName":"ACS Biomarker","companyId":"acs-biomarker","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:02:37.040528+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}